Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease

Genome Medicine

Volumn 6, Issue , 2014, Pages 1-13

  Hoang, Long Truong ^a   Shimizu, Chisato ^b   Ling, Ling ^a   Naim, Ahmad Nazri Mohamed ^a   Khor, Chiea Chuen ^a   Tremoulet, Adriana H ^b   Wright, Victoria ^c   Levin, Michael ^c   Hibberd, Martin L ^a   Burns, Jane C ^b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; B CELL ACTIVATING FACTOR; CARCINOEMBRYONIC ANTIGEN CELL ADHESION MOLECULE 1; CD3 ANTIGEN; CD4 ANTIGEN; CRYOPYRIN; CYTOCHROME P450 26B1; CYTOCHROME P450 REDUCTASE; FRUCTOSE BISPHOSPHATASE; HAPTOGLOBIN; HLA ANTIGEN CLASS 2; I KAPPA B KINASE BETA; IMMUNOGLOBULIN; INFLIXIMAB; INITIATION FACTOR 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; PAXILLIN; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; RELAXIN; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ARTICLE; CELL MIGRATION; CELL MOTILITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY ANEURYSM; DOWN REGULATION; ENTEROVIRUS INFECTION; GENE EXPRESSION PROFILING; GENE TARGETING; GRAM POSITIVE INFECTION; HERPESVIRIDAE; HUMAN; HUMAN ADENOVIRUS INFECTION; HUMAN HERPESVIRUS 6; INNATE IMMUNITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

EID: 84925787027     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0102-6     Document Type: Article

References (40)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H: A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974, 54:271-276.
2. Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, Uehara R, Best BM, Burns JC: Incidence of Kawasaki disease in northern European countries. Pediatr Int 2012, 54:770-772.
3. Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H: Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 2012, 22:216-221.
4. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R: Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996, 94:1379-1385.
5. Taubert KA, Rowley AH, Shulman ST: Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991, 119:279-282.
6. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Meissner HC, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS: A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991, 324:1633-1639.
7. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP: Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998, 17:1144-1148.
8. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, Martin DD, Newburger JW, Burns JC: Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 2008, 153:117-121.
9. Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M: Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 2005, 174:5837-5845.
10. Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA: Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 2007, 8:R261.
11. Sassoli C, Chellini F, Pini A, Tani A, Nistri S, Nosi D, Zecchi-Orlandini S, Bani D, Formigli L: Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-beta/Smad3 signaling. PLoS One 2013, 8:e63896.
12. Hu X, Yu J, Crosby SD, Storch GA: Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci U S A 2013, 110:12792-12797.
13. Herberg JA, Kaforou M, Gormley S, Sumner ER, Patel S, Jones KD, Paulus S, Fink C, Martinon-Torres F, Montana G, Wright VJ, Levin M: Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes. J Infect Dis 2013, 208:1664-1668.
14. R Development Core Team: R: A Language and Environment for Statistical Computing. Viena, Austria: R Foundation for Statistical computing; 2010. [ http://www.R-project.org ]
15. Cheadle C, Vawter MP, Freed WJ, Becker KG: Analysis of microarray data using Z score transformation. J Mol Diagn 2003, 5:73-81.
16. Cheadle C, Cho-Chung YS, Becker KG, Vawter MP: Application of z-score transformation to Affymetrix data. Appl Bioinformatics 2003, 2:209-217.
17. IPA, QIAGEN Redwood City. [ www.qiagen.com/ingenuity ]
18. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G: The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816.
19. Hinz B: Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007, 127:526-537.
20. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC: The role of TGF-beta and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol 2013, 44:189-198.
21. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW, Rowley AH, Shulman ST, Burgner D, Breunis WB, Kuijpers TW, Wright VJ, Levin M, Eleftherohorinou H, Coin L, Popper SJ, Relman DA, Fury W, Lin C, Mellis S, Tremoulet AH, Burns JC: Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 2011, 4:16-25.
22. Murray PJ, Smale ST: Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 2012, 13:916-924.
23. Cohen S, Tacke CE, Straver B, Meijer N, Kuipers IM, Kuijpers TW: A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis 2012, 71:2059-2061.
24. Fury W, Tremoulet AH, Watson VE, Best BM, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Mellis S, Lin C, Burn JC: Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. Hum Immunol 2010, 71:865-873.
25. Nomura I, Abe J, Noma S, Saito H, Gao B, Wheeler G, Leung DY: Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. Pediatr Res 2005, 57:49-55.
26. Ogata S, Ogihara Y, Nomoto K, Akiyama K, Nakahata Y, Sato K, Minoura K, Kokubo K, Kobayashi H, Ishii M: Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone. Pediatr Res 2009, 66:577-584.
27. Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M: Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. J Allergy Clin Immunol 2008, 122:1008-1013. e1008.
28. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, Newburger JW, Kuijpers TW: Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol 2005, 141:183-188.
29. Senzaki H: The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006, 91:847-851.
30. Nagaishi T, Chen Z, Chen L, Iijima H, Nakajima A, Blumberg RS: CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol 2008, 1:S39-S42.
31. Xia Y, Hong H, Ye L, Wang Y, Chen H, Liu J: Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients. J Proteomics 2013, 84:78-91.
32. Yutani C, Go S, Kamiya T, Hirose O, Misawa H, Maeda H, Kozuka T, Onishi S: Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med 1981, 105:470-473.
33. Takeuchi H, Yokota A, Ohoka Y, Iwata M: Cyp26b1 regulates retinoic acid-dependent signals in T cells and its expression is inhibited by transforming growth factor-beta. PLoS One 2011, 6:e16089.
34. Matsui T, Miyamoto K, Kubo A, Kawasaki H, Ebihara T, Hata K, Tanahashi S, Ichinose S, Imoto I, Inazawa J, Kudoh J, Amagai M: SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing. EMBO Mol Med 2011, 3:320-333.
35. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DY: Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 1988, 7:863-866.
36. Woon PY, Chang WC, Liang CC, Hsu CH, Klahan S, Huang YH, Chang WP, Kuo HC: Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in Taiwan. Evid Based Complement Alternat Med 2013, 2013:605123.
37. Bernard D, Mehul B, Thomas-Collignon A, Delattre C, Donovan M, Schmidt R: Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis. J Invest Dermatol 2005, 125:278-287.
38. Zhang H, Muders MH, Li J, Rinaldo F, Tindall DJ, Datta K: Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer. Cancer Res 2008, 68:8770-8778.
39. Singer BB, Klaile E, Scheffrahn I, Muller MM, Kammerer R, Reutter W, Obrink B, Lucka L: CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur J Immunol 2005, 35:1949-1959.
40. Sun G, Wang X, Chen J, Ma R, Li F, Chen L, Xiao Y: Primary repair of tetralogy of Fallot in infants: transatrial/transpulmonary or transventricular approach. Asian J Surg 2013, 36:137-143.